[Methyl(nitroso)amino]acetic acid

Suppliers

Names

[ CAS No. ]:
13256-22-9

[ Name ]:
[Methyl(nitroso)amino]acetic acid

[Synonym ]:
Acetic acid, 2-(methylnitrosoamino)-
N-Nitrososarcosine
2-[methyl(nitroso)amino]acetic acid
[Methyl(nitroso)amino]acetic acid

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
353.1±25.0 °C at 760 mmHg

[ Melting Point ]:
66-67ºC

[ Molecular Formula ]:
C3H6N2O3

[ Molecular Weight ]:
118.091

[ Flash Point ]:
167.4±23.2 °C

[ Exact Mass ]:
118.037842

[ PSA ]:
69.97000

[ LogP ]:
-1.00

[ Vapour Pressure ]:
0.0±1.7 mmHg at 25°C

[ Index of Refraction ]:
1.504

[ Storage condition ]:
20°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VQ3150000
CHEMICAL NAME :
Sarcosine, N-nitroso-
CAS REGISTRY NUMBER :
13256-22-9
BEILSTEIN REFERENCE NO. :
1756162
LAST UPDATED :
199612
DATA ITEMS CITED :
11
MOLECULAR FORMULA :
C3-H6-N2-O3
MOLECULAR WEIGHT :
118.11
WISWESSER LINE NOTATION :
QV1N1&NO

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NATWAY Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- Volume(issue)/page/year: 50,100,1963
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
184 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 35,1981,1975 ** TUMORIGENIC DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
29 gm/kg/41W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 19,1077,1969
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
118 gm/kg/56W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Sense Organs and Special Senses (Ear) - effect, not otherwise specified Lungs, Thorax, or Respiration - tumors
REFERENCE :
FEPRA7 Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. Volume(issue)/page/year: 33,596,1974 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 17,327,1978 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 17,327,1978 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-FRANCE;Carcinogen JAN 1993

Safety Information

[ Hazard Codes ]:
Xn

[ RIDADR ]:
UN 2811

[ Packaging Group ]:
III

[ Hazard Class ]:
6.1(b)

Precursor & DownStream

Precursor

  • Sarcosine
  • N,N-Dimethylglycine
  • 2-[methyl(nitroso)amino]acetamide
  • Diazald
  • S-nitroso-N-acetylpenicillamine

DownStream

  • N-NITROSARCOSINE
  • Sarcosine
  • 3-Methylsydnone
  • N-Nitrososarcosine Methyl Ester

Related Compounds

  • [(2H3)Methyl(nitroso)amino]acetic acid
  • 2-[(4-chlorophenyl)methyl-nitroso-amino]acetic acid
  • Acetic acid,2-[[(4-methylphenyl)methyl]nitrosoamino]-
  • (CYCLOPENTYL-METHYL-AMINO)-ACETIC ACID
  • [ethyl(methyl)amino]acetic acid
  • 2-[[(2R)-2-acetamido-3-methyl-butanoyl]-nitroso-amino]acetic acid
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • 2-(trifluoroacetamido)-4H,5H,6H-cyclopenta[b]thiophene-3-carboxylic acid
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide